Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982397 · ClinicalTrials.gov registry record · NA
Safety and Clinical Performance of the Protecta ICD and CRT-D
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 2,770
- Enrollment target
NCT00982397 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 2,770 participants.
The verdict
NCT00982397, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,770 participants
- Enrollment target
Study Summary
The purpose of the study is two-fold. In Phase I (Protecta Clinical Study), system performance will be evaluated. In Phase II (PainFree SST), the inappropriate shock-free rate at one year of subjects implanted with a Medtronic Protecta implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) will be evaluated.
Interventions
- DEVICE Protecta VR-ICD
- DEVICE Protecta DR-ICD or CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,770 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982397
The ClinicalTrials.gov registry entry for NCT00982397 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,770 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Protecta VR-ICD is the first listed.
NCT00982397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00982397 about?
NCT00982397 is a clinical study titled "Safety and Clinical Performance of the Protecta ICD and CRT-D". The purpose of the study is two-fold. In Phase I (Protecta Clinical Study), system performance will be evaluated. In Phase II (PainFree SST), the inappropriate shock-free rate at one year of subjects implanted with a Medtronic Protecta implantable cardioverter defibrillator (ICD) and cardiac resynch...
What is the current status of trial NCT00982397?
This trial is currently completed. It is a NA study. The enrollment target is 2,770 participants. The study started on 2009-09. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00982397?
The interventions under investigation include: Protecta VR-ICD (DEVICE), Protecta DR-ICD or CRT-D (DEVICE).
Who is sponsoring clinical trial NCT00982397?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.